Cancer Research 1992-12-15

Enhancement of xanthine dehydrogenase mediated mitomycin C metabolism by dicumarol.

D L Gustafson, C A Pritsos

Index: Cancer Res. 52(24) , 6936-9, (1992)

Full Text: HTML

Abstract

These studies examined the effect of dicumarol on xanthine dehydrogenase (XDH), an enzyme recently shown to bioreduce mitomycin C. Dicumarol, which has previously been shown to inhibit xanthine oxidase (XO), inhibited both XDH and XO mediated conversion of xanthine to uric acid but potentiated the metabolism of mitomycin C by XDH and XO. Formation of 2,7-diaminomitosene following mitomycin C bioactivation by XDH was increased 3-fold aerobically and 4-fold hypoxically when 20 microM dicumarol was included in the reaction mixture. XO mediated metabolism of mitomycin C hypoxically was increased approximately 50% by the inclusion of dicumarol.


Related Compounds

Related Articles:

Kinetics and mechanism of mitomycin C bioactivation by xanthine dehydrogenase under aerobic and hypoxic conditions.

1993-11-15

[Cancer Res. 53(22) , 5470-4, (1993)]

catena-Poly[diaquabis(5-chloropyridinium-2-olato-kappaO)copper(II)]-mu-pyrazine-kappa2N:N'] diperchlorate].

2002-04-01

[Acta Crystallogr. C 58(Pt 4) , M270-2, (2002)]

More Articles...